This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FM-VP4

Pharmachem Laboratories, Inc.

Drug Names(s): disodium ascorbyl phytostanol phosphates

Description: FM-VP4 represents a new class of cardiovascular pharmaceuticals known as cholesterol transport inhibitors. FM-VP4 is a water-soluble analogue of phytostanol, which has demonstrated significant lipid-lowering and anti-atherosclerotic properties in pre-clinical trials.

Deal Structure: FM-VP4 was originally developed by Forbes Medi-Tech.

In August 2010, Forbes Medi-Tech announced that the Company completed the previously announced sale of substantially all of its assets to Pharmachem Laboratories for cash consideration of US$4.0 million.


FM-VP4 News

Pink Sheet Forbes Medi-Tech


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug